Chick-fil-A is amending its antibiotic policy to 'No Antibiotics Important to Human Medicine' from 'No Antibiotics Ever' across over 3,000 locations in the US starting this spring.

The policy change is driven by sourcing challenges to meet the demand for antibiotic-free chicken while ensuring a consistent supply of high-quality chicken.

Despite the policy shift, Chick-fil-A commits to no added fillers, artificial preservatives, or steroids, and adherence to Animal Wellbeing Standards.

Similar policy reversals have occurred in other companies, notably Tyson Foods, highlighting industry-wide struggles with antibiotic use in livestock.

The change reflects the tension between consumer demand for quality food and public health concerns over antibiotic resistance, a challenge recognized by the FDA.

Chick-fil-A's expansion plans into Europe and Asia by 2030 underscore the policy's potential global impact, affecting operations in existing US, Canadian, and Puerto Rican markets.